Chief Physician, Master's Supervisor. Specializes in the diagnosis and treatment of coronary heart disease, various valvular diseases, aortic aneurysm and aortic dissection. He obtained his Doctoral degree from Zhongshan Hospital, Fudan University in 2004 and has since been engaged in clinical practice and scientific research. As a visiting scholar, he conducted academic exchanges at the Berlin Heart Centre, Humboldt‑Universität zu Berlin in Germany from 2007. He presided over the General Program of the National Natural Science Foundation of China titled "Study on the Effect and Mechanism of Advanced Glycation End‑Products Aggravating Venous Graft Vascular Remodeling". He was appointed as a member of the National Natural Science Foundation Review Expert Database in 2018. He has participated as a key member in three other National Natural Science Foundation projects and multiple research projects sponsored by the Shanghai Science and Technology Commission. He was selected for the Talent Training Program of Zhongshan Hospital, Fudan University in 2019. As the first author and corresponding author, he has published more than 20 basic and clinical research papers in SCI journals, with a cumulative impact factor of over 90 points. The highest single‑paper impact factor is 15 points from a Lancet sub‑journal. He holds two invention patents, one of which has been transformed, with total research funding of more than 1 million RMB. As a core team member, he has won the First‑Class Award for Scientific and Technological Progress issued by the National Health Commission and Shanghai Municipality.